arrow
S

Sławomir Mańdziuk

Medical University
H指数:17
被引数:4,066

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
2025-11-010
OA
Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy

检查点抑制剂免疫治疗中吸烟状态、毒性和生存率之间的关系

2024-11-250
OAAI
Leveraging innate and adaptive immunity with AFM24 and atezolizumab in metastatic gastric cancer

利用AFM24和atezolizumab增强固有免疫和适应性免疫在转移性胃癌中的应用

2024-09-010
PRE
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
2021-02-0813
OAAI
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer

北极: durvalumab联合或不联合tremelimumab作为转移性非小细胞肺癌的三线或晚期治疗

2020-05-01113
OAAI
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
LANCET
IF88.5
2019-11-011.4K
PREAI